Drug
IDN 5109 clinical trials
Also written ortataxel.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2001
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2001 (3)
| Year | Studies |
|---|---|
| 2001 | 3 |
| 2002 | 3 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 2
Bayer (3) · Theradex (2) · Roswell Park Cancer Institute (1) · Mario Negri Institute for Pharmacological Research (1)
Studies
Open first, then newest update. How each study uses IDN 5109 is read from its arms, and is right about nine times in ten.
Testing it · 7
- BAY 59-8862 in Treating Patients With Non-Small Cell Lung CancerCompletedPhase 2Roswell Park Cancer InstituteNCT00054314Written as ortataxel
- An Efficacy Study Of Ortataxel In Recurrent GlioblastomaCompletedPhase 2Mario Negri Institute for Pharmacological ResearchNCT01989884Written as Ortataxel
- Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer PatientsCompletedPhase 2BayerNCT00044525Written as BAY59-8862 (Cytotoxic Taxane)
- Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell CarcinomaCompletedPhase 2BayerNCT00044564Written as Bay 59-8862
- Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer PatientsCompletedPhase 2BayerNCT00044538Written as BAY59-8862 (Cytotoxic Taxane)
- BAY 59-8862 in Treating Patients With Advanced Kidney CancerStatus unknownPhase 2TheradexNCT00039169Written as ortataxel
- BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's LymphomaStatus unknownPhase 2TheradexNCT00039156Written as ortataxel
Codes
What other systems call IDN 5109 · ClinicalTrials.gg INT004215
- MeSH (NLM) C404743IDN 5109Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 8H61Y4E29NORTATAXELConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C404743 | IDN 5109 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 8H61Y4E29N | ORTATAXEL | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.